Paul Gerard Richardson (Paul G Richardson, Paul Richardson, Paul G Richardson)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 71

Top Topics

Multiple Myeloma

Molecular Dynamics

Acute Lymphoblastic Leukemia

Top Venues

British journal of haematology

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Clifton C Mo, Andrew J Yee, Shonali Midha, Monique A Hartley-Brown, Omar Nadeem, Elizabeth K O'Donnell, Giada Bianchi, Adam S Sperling, Jacob P Laubach, Paul Gerard Richardson
Selinexor: Targeting a novel pathway in multiple myeloma. EJHaem 4 (3) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Selim Corbacioglu, Stephan A Grupp, Paul Gerard Richardson, Rafael Duarte, Antonio Pagliuca, Tapani Ruutu, Kris Mahadeo, Enric Carreras
Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answer. Bone marrow transplantation (2023)
Paul Gerard Richardson, Thierry Facon, Christopher P Venner, Nizar J Bahlis, Fritz Offner, Darrell White, Lionel Karlin, Lotfi Benboubker, Eric Voog, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Miguel Villarreal, Philip Twumasi-Ankrah, Richard Labotka, Robert M Rifkin, Sagar Lonial, Shaji K Kumar, S Vincent Rajkumar, Philippe Moreau
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial. EJHaem 4 (4) (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Zachary Ryan McCaw, Paul Gerard Richardson, Lee-Jen Wei
Assessing the Ability of Long Noncoding RNA Expression to Predict Patient Outcomes in Pediatric AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Schjesvold Fredrik, Heinz Ludwig, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Haifaa Abdulhaq, Stefan Norin, Marcus Thuresson, Nicolaas A Bakker, Paul Gerard Richardson, Pieter Sonneveld
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study. European journal of haematology (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Shonali Midha, Monique A Hartley-Brown, Clifton C Mo, Shahrier Hossain, Omar Nadeem, Elizabeth K O'Donnell, Giada Bianchi, Adam S Sperling, Jacob P Laubach, Paul Gerard Richardson
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma. Expert opinion on drug safety (2023)
Mohamad Mohty, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Mohamad Mohty, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mohamad Mohty, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Shaji K Kumar, Lawrence Baizer, Natalie S Callander, Sergio A Giralt, Jens Hillengass, Boris Freidlin, Antje Hoering, Paul Gerard Richardson, Elena I Schwartz, Anthony Reiman, Suzanne Lentzch, Philip L McCarthy, Sundar Jagannath, Andrew J Yee, Richard F Little, Noopur S Raje
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood cancer journal 12 (6) (2022)
Peter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, Janusz Krawczyk, Andrew J Yee, Oonagh Gilligan, Mary R Cahill, Jacalyn Rosenblatt, John Quinn, Philip T Murphy, Heidi DiPietro, Meegahage Ratnakanthi Perera, Gerard M Crotty, Kristen Cummings, Patrick J Hayden, Paul Browne, Alexandra Savell, Hilary M O'Leary, Denis O'Keeffe, Kelly Masone, Brian J Hennessy, Thomas Guerrero Garcia, Kathleen Scott, Khalid Saeed, Giada Bianchi, Paul Dowling, Ciara Tierney, Paul Gerard Richardson
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma. American journal of hematology 97 (5) (2022)
Johannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, Ricardo A Pinto, Julia Frede, Praveen Anand, Giada Bianchi, Guangwu Guo, Sayalee Potdar, Charles Seifer, Monica S Nair, Antonis Kokkalis, Jake A Kloeber, Samantha Shapiro, Lillian Budano, Mason Mann, Robb Friedman, Brea Lipe, Erica Campagnaro, Elizabeth K O'Donnell, Cheng-Zhong Zhang, Jacob P Laubach, Nikhil C Munshi, Paul Gerard Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma. Leukemia 36 (4) (2022)
Joan Bladé, Meral Beksac, Jo Caers, Artur Jurczyszyn, Marie von Lilienfeld-Toal, Philippe Moreau, Leo Rasche, Laura Rosinol, Saad Z Usmani, Elena Zamagni, Paul Gerard Richardson
Extramedullary disease in multiple myeloma: a systematic literature review. Blood cancer journal 12 (3) (2022)
Meletios- Athanasios Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Phillipe Moreau, Naoki Takezako, Mitsuo Hori, Xavier Leleu, Richard LeBlanc, Kenshi Suzuki, Marc-Steffen Raab, Paul Gerard Richardson, Mihaela Popa McKiver, Ying-Ming Jou, David Yao, Prianka Das, Jesús San F Miguel
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej J Jakubowiak, Yvonne Efebera, Brandi N Reeves, Tanya Wildes, Sarah A Holstein, Larry D Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, J Blake Bartlett, Jessica Vermeulen, Thomas S Lin, Paul Gerard Richardson, Peter Voorhees
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN. Blood cancer journal 12 (4) (2022)
Monique A Hartley-Brown, Paul Gerard Richardson
Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon? Exploration of targeted anti-tumor therapy 3 (1) (2022)
Meletios- Athanasios Dimopoulos, Joseph Mikhael, Evangelos Terpos, Xavier Leleu, Philippe Moreau, Joan Bladé, Jin Seok Kim, Keith Stockerl-Goldstein, Paul Gerard Richardson
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment. Therapeutic advances in hematology 13 (2022)
Douglas W Sborov, Muhamed Baljevic, Brandi Reeves, Jacob P Laubach, Yvonne A Efebera, Cesar Rodriguez, Luciano José Megale Costa, Ajai Chari, Rebecca Silbermann, Sarah A Holstein, Larry D Anderson, Jonathan L Kaufman, Nina Shah, Huiling Pei, Sharmila Patel, Annelore Cortoos, J Blake Bartlett, Jessica Vermeulen, Thomas S Lin, Peter M Voorhees, Paul Gerard Richardson
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. British journal of haematology 199 (3) (2022)
Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Kemal Samur, Tomasz Sewastianik, Daisuke Ogiya, Gang An, Shaobing Gao, Li Yang, Tong Ji, Giada Bianchi, Kenneth Wen, Yu-Tzu Tai, Nikhil Munshi, Paul Gerard Richardson, Ruben Carrasco, Yong Cang, Kenneth C Anderson
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Science advances 7 (23) (2021)
Paul Gerard Richardson, Simon J Harrison, Sara Bringhen, Fredrik Schjesvold, Kwee Yong, Frank Campana, Solenn Le-Guennec, Sandrine Macé, Meletios A Dimopoulos
Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study. Future oncology (London, England) 17 (34) (2021)
Agnieszka Blum, Despina Bazou, Kay R Ting, Giada Bianchi, Monisa Mahandran, Harshini Mahandran, Stephen Eustace, Paul Gerard Richardson, Peter O'Gorman
Successful treatment of solitary bone plasmacytoma and bone remineralisation with novel biological agents leading to new bone formation - a case series. British journal of haematology 193 (4) (2021)
Sosana Delimpasi, Maria Victoria Mateos, Holger W Auner, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Hang Quach, Halyna Pylypenko, Roman Hájek, Xavier Leleu, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Reuben Benjamin, Mamta Krishnan Garg, Vadim Doronin, Yair Levy, Phillipe Moreau, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Paul Gerard Richardson, Sebastian Grosicki
Efficacy and Tolerability of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Standard Twice-Weekly Bortezomib and Dexamethasone in Previously Treated Multiple Myeloma with Renal Impairment: Subgroup Analysis from the BOSTON Study. American journal of hematology (2021)
Paul Gerard Richardson, Shaji K Kumar, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Luděk Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W Baker, Sharon R Jackson, Anne-Marie Stoppa, Peter Gimsing, Laurent Garderet, Cyrille Touzeau, Francis K Buadi, Jacob P Laubach, Michele Cavo, Mohamed Darif, Richard Labotka, Deborah Berg, Philippe Moreau
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
David García-Bernal, Edward Richardson, Israel Vlodavsky, Carmelo Carlo-Stella, Massimo Iacobelli, Rubén Jara, Paul Gerard Richardson, José María Moraleda
Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy. EJHaem (2021)
Omar Nadeem, Paul Gerard Richardson
The initial management of multiple myeloma in the era of novel agents: 2021 and beyond. British journal of haematology 193 (2) (2021)
Paul Gerard Richardson, Marta Palomo, Nancy A Kernan, Gerhard Carl Hildebrandt, Nelson J Chao, Enric Carreras
The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae. Bone marrow transplantation 56 (12) (2021)
Cyrille Hulin, Meral Beksac, Hugh J Goodman, Ivan Spicka, Adrian Alegre, Miles Prince, Frank Campana, Greg Finn, Solenn Le-Guennec, Sandrine Macé, Stéphane Muccio, Alexandra Tavernier, Marie-Claude Rouchon, Paul Gerard Richardson
Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma. Blood cancer journal 11 (10) (2021)
Fabio Malavasi, Angelo C Faini, Fabio Morandi, Barbara Castella, Danny Incarnato, Salvatore Oliviero, Alberto L Horenstein, Massimo Massaia, Niels W C J van de Donk, Paul Gerard Richardson
Molecular dynamics of targeting CD38 in multiple myeloma. British journal of haematology 193 (3) (2021)
Paul Gerard Richardson, Aurore Perrot, Hiroyuki Takamatsu, null null
Revised international staging system allocation in the ICARIA-MM study: Practical challenges and impact on outcome. EJHaem 3 (1) (2021)
Schjesvold Fredrik, Sara Bringhen, Paul Gerard Richardson, Aurore Perrot, Xavier Leleu, Phillipe Moreau, Meletios- Athanasios Dimopoulos, Cyrille Hulin, Christina Tekle, Meredith C Foster, Elizabeth M Poole, Helgi van de Velde, Thierry Facon
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. American journal of hematology 96 (11) (2021)
Saad Z Usmani, Chatchada Karanes, William I Bensinger, Anita D Souza, Noopur Raje, Sascha A Tuchman, Douglas Sborov, Jacob P Laubach, Giada Bianchi, Dheepak Kanagavel, Rao Saleem, Franck Dubin, Frank Campana, Paul Gerard Richardson
Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. Leukemia 35 (12) (2021)
Peter M Voorhees, Vera J Suman, Sascha A Tuchman, Jacob P Laubach, Hani Hassoun, Yvonne A Efebera, Flora Mulkey, Misty Bova-Solem, Katelyn Santo, Destin Carlisle, Philip L McCarthy, Paul Gerard Richardson
A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202). American journal of hematology 96 (12) (2021)
Laura Rosinol, Meral Beksac, Elena Zamagni, Niels W C J Van de Donk, Kenneth C Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios- Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria-Victoria Mateos-Manteca, Giampaolo Merlini, Mohamad Mohty, Phillipe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z Usmani, Karin Vanderkerken, David H Vesole, Anders Waage, Sonja Zweegman, Paul Gerard Richardson, Joan Bladé
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British journal of haematology 194 (3) (2021)
Paul Gerard Richardson, Phillipe Moreau
Reply to G. R. Mohyuddin et al and A. Garfall et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Simon James Harrison, Aurore Perrot, Adrian Alegre, David Simpson, Ming Chung Wang, Andrew Spencer, Sosana Delimpasi, Cyrille Hulin, Kazutaka Sunami, Thierry Facon, Philip Vlummens, Kwee L Yong, Frank Campana, Marlène Inchauspé, Sandrine Macé, Marie-Laure Risse, Helgi van de Velde, Paul Gerard Richardson
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics. British journal of haematology 194 (1) (2021)
Sara Bringhen, Peter M Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Pieter Sonneveld, Catriona Byrne, Eva Nordström, Johan Harmenberg, Jakob Obermüller, Paul Gerard Richardson
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1. British journal of haematology 193 (6) (2021)
Sherilyn A Tuazon, Leona A Holmberg, Omar Nadeem, Paul Gerard Richardson
A clinical perspective on plasma cell leukemia; current status and future directions. Blood cancer journal 11 (2) (2021)
Jooeun Bae, Fabrizio Accardi, Teru Hideshima, Yu-Tzu Tai, Rao Prabhala, Aaron Shambley, Kenneth Wen, Sean Rowell, Paul Gerard Richardson, Nikhil C Munshi, Kenneth C Anderson
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma. Leukemia (2021)
Johannes Moritz Waldschmidt, Jake A Kloeber, Praveen Anand, Julia Frede, Antonis Kokkalis, Valeriya Dimitrova, Sayalee Potdar, Monica S Nair, Tushara Vijaykumar, Nam Gyu Im, Amy Guillaumet-Adkins, Nitish Chopra, Hannah Stuart, Lillian Budano, Noori Sotudeh, Guangwu Guo, Clemens Grassberger, Andrew J Yee, Jacob P Laubach, Paul Gerard Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Jacob P Laubach, Sascha A Tuchman, Jacalyn M Rosenblatt, Constantine S Mitsiades, Kathleen Colson, Kelly Masone, Diane Warren, Robert A Redd, Dena Grayson, Paul Gerard Richardson
Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma. Blood cancer journal 11 (2) (2021)
Paul Gerard Richardson, Thierry Facon, William I Bensinger, Xavier Leleu, Frank Campana, Sandrine Macé, Marielle Chiron, Helgi van de Velde, Joseph Mikhael
Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma. Blood cancer journal 11 (3) (2021)
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Maria-Victoria Mateos-Manteca, Michele Cavo, Christopher Maisel, Adrían Alegre, Albert Oriol, Anastasios Raptis, Paula Rodriguez-Otero, Amitabha Mazumder, Jacob P Laubach, Omar Nadeem, Anna Sandberg, Marie Orre, Anna Torrång, Nicolaas A Bakker, Paul Gerard Richardson
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. British journal of haematology (2021)
Paul Gerard Richardson, Sundar Jagannath, Ajai Chari, Dan T Vogl, Meletios A Dimopoulos, Philippe Moreau, David Dingli, Lee-Jen Wei, Joshua Richter, Noa Biran, David Siegel, William Reichmann, Lingling Li, Shijie Tang, Jean-Richard Saint-Martin, Anita Joshi, Michael Kauffman, Jatin Shah, Sharon Shacham, Sagar Lonial
Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myeloma. EJHaem 2 (1) (2020)
Dickran Kazandjian, Clifton C Mo, Carl Ola Landgren, Paul Gerard Richardson
The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift? British journal of haematology 191 (5) (2020)
Paul Gerard Richardson, Arnon Nagler, Dina Ben-Yehuda, Ashraf Badros, Parameswaran N Hari, Roman Hájek, Ivan Spicka, Hakan Kaya, Richard LeBlanc, Sung-Soo Yoon, Kihyun Kim, Joaquin Martinez-Lopez, Moshe Mittelman, Ofer Shpilberg, Paul Blake, Teru Hideshima, Kathleen Colson, Jacob P Laubach, Irene M Ghobrial, Merav Leiba, Moshe E Gatt, Peter Sportelli, Michael Chen, Kenneth C Anderson
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib. EJHaem 1 (1) (2020)
Paul Gerard Richardson, Albert Oriol, Alessandra Larocca, Joan Bladé, Michele Cavo, Paula Rodriguez-Otero, Xavier Leleu, Omar Nadeem, John W Hiemenz, Hani Hassoun, Cyrille Touzeau, Adrián Alegre, Agne Paner, Christopher Maisel, Amitabha Mazumder, Anastasios Raptis, Jan S Moreb, Kenneth C Anderson, Jacob P Laubach, Sara Thuresson, Marcus Thuresson, Catriona Byrne, Johan Harmenberg, Nicolaas A Bakker, María-Victoria Mateos, null null
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)
Paul Gerard Richardson, Angela R Smith, Nancy A Kernan, Leslie Lehmann, Robert J Soiffer, Robert J Ryan, William Tappe, Stephan Grupp
Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation. British journal of haematology 190 (4) (2020)
Torben Plesner, Hendrik-Tobias Arkenau, Francesca Gay, Monique C Minnema, Mario Boccadoro, Phillipe Moreau, Jamie Cavenagh, Aurore Perrot, Jacob P Laubach, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M Schecter, Paul Gerard Richardson
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study. British journal of haematology 186 (3) (2019)
Giada Bianchi, Paul Gerard Richardson
Towards a better understanding of monoclonal gammopathy of renal significance. British journal of haematology 186 (5) (2019)
Clifton C Mo, Paul Gerard Richardson
Pomalidomide in lenalidomide-refractory multiple myeloma: Far from futile. British journal of haematology 188 (4) (2019)
Niels W C J van de Donk, Tineke Casneuf, Alessandro Di Cara, Paul W Parren, Sonja Zweegman, Berris van Kessel, Henk M Lokhorst, Saad Z Usmani, Sagar Lonial, Paul Gerard Richardson, Christopher Chiu, Tuna Mutis, Inger S Nijhof, A Kate Sasser
Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma. British journal of haematology 184 (3) (2018)
Paul Gerard Richardson, William I Bensinger, Carol Ann Huff, Caitlin L Costello, Nikoletta Lendvai, Jesus G Berdeja, Larry D Anderson, David S Siegel, Daniel Lebovic, Sundar Jagannath, Jacob P Laubach, Keith E Stockerl-Goldstein, Long Kwei, Fong Clow, Laurence Elias, Zeena Salman, Thorsten Graef, Elizabeth Bilotti, Ravi Vij
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. British journal of haematology 180 (6) (2018)
Paul Gerard Richardson, Craig C Hofmeister, Cara A Rosenbaum, Myo Htut, David H Vesole, Jesus G Berdeja, Michaela Liedtke, Ajai Chari, Stephen D Smith, Daniel Lebovic, Noopur Raje, Catriona Byrne, Eileen Liao, Neeraj Gupta, Alessandra Di Bacco, Jose Estevam, Deborah Berg, Rachid Baz
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma. British journal of haematology 182 (2) (2018)
Cindy Varga, Michelle Maglio, Irene M Ghobrial, Paul Gerard Richardson
Current use of monoclonal antibodies in the treatment of multiple myeloma. British journal of haematology 181 (4) (2018)
Elizabeth K O' Donnell, Jacob P Laubach, Andrew J Yee, Tianqi Chen, Carol Ann Huff, Frank G Basile, Philip M Wade, Claudia E Paba-Prada, Irene M Ghobrial, Robert L Schlossman, Jill N Burke, Cynthia C Harrington, Kathleen J Lively, Hannah F Lyons, Nikhil C Munshi, Kenneth C Anderson, Lorenzo Trippa, Paul Gerard Richardson, Noopur S Raje
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma. British journal of haematology 182 (2) (2018)
Sundar Jagannath, Jacob P Laubach, Ellice Wong, Keith Stockerl-Goldstein, Cara Rosenbaum, Madhav Dhodapkar, Ying-Ming Jou, Mark Lynch, Michael Robbins, Suresh Shelat, Kenneth C Anderson, Paul Gerard Richardson
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study. British journal of haematology 182 (4) (2018)
Paul Gerard Richardson, Robert L Schlossman, Anuja N Roy, Ashok Panneerselvam, Suddhasatta Acharyya, Monika Sopala, Sagar Lonial
Patient-reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled PANORAMA-1 trial. British journal of haematology 181 (5) (2018)
Nancy A Kernan, Stephan Grupp, Angela R Smith, Sally Arai, Brandon M Triplett, Joseph H Antin, Leslie Lehmann, Tsiporah Shore, Vincent T Ho, Nancy Bunin, Massimo Iacobelli, Wei Liang, Robin Hume, William Tappe, Robert Soiffer, Paul Gerard Richardson
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. British journal of haematology 181 (6) (2018)
Cindy Varga, Jacob P Laubach, Kenneth C Anderson, Paul Gerard Richardson
Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma. British journal of haematology 181 (4) (2018)
Michael G Fradley, John D Groarke, Jacob P Laubach, Melissa Alsina, Daniel J Lenihan, Robert Frank Cornell, Michelle Maglio, Kenneth H Shain, Paul Gerard Richardson, Javid Moslehi
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British journal of haematology 180 (2) (2017)
Danka Cholujova, Zdenka Bujnakova, Erika Dutkova, Teru Hideshima, Richard W Groen, Constantine S Mitsiades, Paul Gerard Richardson, David M Dorfman, Peter Balaz, Kenneth C Anderson, Jana Jakubikova
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. British journal of haematology 179 (5) (2017)
Andrew Spencer, Simon Harrison, Jeffrey Zonder, Ashraf Badros, Jacob P Laubach, Krystal Bergin, Amit Khot, Todd Zimmerman, Dharminder Chauhan, Nancy Levin, Ann MacLaren, Steven D Reich, Mohit Trikha, Paul Gerard Richardson
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results. British journal of haematology 180 (1) (2017)